SEP 07, 2019 11:50 AM PDT

New MRI scan can reveal molecular changes in the brain

MRI scans give us pictures of the brain that depict the physical structure of brain tissue. Now, researchers discovered a way to determine the biological makeup of the brain using an MRI – a powerful method that can help scientists understand the molecular basis of normal aging and neurodegenerative disease.

In a paper published in Nature Communications, Dr. Aviv Mezer and his research team at the Hebrew University of Jerusalem (HUJI)’s Edmond and Lily Safra Center for Brain Sciences used a new quantitative imaging approach to extract molecular information about brain tissue from an MRI signal.

"Instead of images, our quantitative MRI model provides molecular information about the brain tissue we're studying. This could allow doctors to compare brain scans taken over time from the same patient, and to differentiate between healthy and diseased brain tissue, without resorting to invasive or dangerous procedures, such as brain tissue biopsies," explained Mezer.

Apart from the obvious indicators of aging - going grey, wrinkles, memory and cognitive problems – how do we know if someone’s brain is aging normally, or developing a disease? Biology may be key. Normal aging and neurodegenerative diseases, such as Alzheimer’s and Parkinson’s disease, create biological “signatures” in the brain, such as differences in the lipid or protein content of brain tissue.

The biological basis of aging is very complex – current theories of aging suggest that aging is not uniform. Rather, each molecule, cell, or system in the body deteriorates with age for different reasons. This pattern is called ‘mosaic aging’, and data gathered from Mezer’s new MRI method debunks prior theories about the aging process. These theories posit that a set of core biological factors, including chromosome attrition and hormonal dysregulation, are responsible for decreased cognitive abilities as we age.

So, not only will this method speed up diagnostics of neurodegenerative disease, studying the molecular landscape of the brain will greatly advance our knowledge of how specific molecules, cells, and brain regions may differently contribute to aging.

Source: EurekAlert!, MedicalExpress

About the Author
You May Also Like
SEP 16, 2019
Genetics & Genomics
SEP 16, 2019
Bipolar Disorder & Schizophrenia Linked to Epigenetic Hotspot
Researchers may have found a way to develop better therapeutics and test for the diseases, which are difficult to diagnose and treat....
SEP 16, 2019
Cell & Molecular Biology
SEP 16, 2019
New Neurons Found to Develop in Older Adult Brains
There has been controversy surrounding the relatively recent idea that new nerve cells grow in adult brains....
SEP 16, 2019
Microbiology
SEP 16, 2019
Rising Cases of Encephalitis and Death in India
Children in eastern India have been dying of encephalitis. Around 400 kids have complained of dizziness, confusion and fever since the start of the year....
SEP 16, 2019
Cell & Molecular Biology
SEP 16, 2019
Understanding the Spread of Parkinson's from the Gut to the Brain
Parkinson's disease, a neurodegenerative disorder impacting the brain, can begin in the gut....
SEP 16, 2019
Health & Medicine
SEP 16, 2019
Ketamine is not an opioid, and treats depression in a novel way
In March, the U.S. Food and Drug Administration approved ketamine nasal spray to treat depression. Ketamine has gotten a bad rep as an opioid - which it is...
SEP 16, 2019
Drug Discovery
SEP 16, 2019
What does MDMA Therapy Look Like?
The Multidisciplinary Association for Psychedelic Studies (MAPS) aims to create an FDA-approved standardized MDMA-assisted psychotherapy practice for PTSD ...
Loading Comments...